<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Transl Neurodegener</journal-id>
<journal-id journal-id-type="iso-abbrev">Transl Neurodegener</journal-id>
<journal-title-group>
<journal-title>Translational Neurodegeneration</journal-title>
</journal-title-group>
<issn pub-type="epub">2047-9158</issn>
<publisher>
<publisher-name>BioMed Central</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28855981</article-id>
<article-id pub-id-type="pmc">5575945</article-id>
<article-id pub-id-type="publisher-id">93</article-id>
<article-id pub-id-type="doi">10.1186/s40035-017-0093-5</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Role of BACE1 in Alzheimer’s synaptic function</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Das</surname>
<given-names>Brati</given-names>
</name>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7195-7617</contrib-id>
<name>
<surname>Yan</surname>
<given-names>Riqiang</given-names>
</name>
<address>
<phone>216-445-2690</phone>
<email>yanr@ccf.org</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<aff id="Aff1"><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0675 4725</institution-id><institution-id institution-id-type="GRID">grid.239578.2</institution-id><institution>Department of Neurosciences, </institution><institution>Lerner Research Institute, Cleveland Clinic, </institution></institution-wrap>9500 Euclid Avenue/NC30, Cleveland, OH 44195 USA </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>30</day>
<month>8</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>30</day>
<month>8</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>6</volume>
<elocation-id>23</elocation-id>
<history>
<date date-type="received">
<day>23</day>
<month>6</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>15</day>
<month>8</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s). 2017</copyright-statement>
<license license-type="OpenAccess">
<license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p id="Par1">Alzheimer’s disease (AD) is the most common age-dependent disease of dementia, and there is currently no cure available. This hallmark pathologies of AD are the presence of amyloid plaques and neurofibrillary tangles. Although the exact etiology of AD remains a mystery, studies over the past 30 have shown that abnormal generation or accumulation of β-amyloid peptides (Aβ) is likely to be a predominant early event in AD pathological development. Aβ is generated from amyloid precursor protein (APP) via proteolytic cleavage by β-site APP cleaving enzyme 1 (BACE1). Chemical inhibition of BACE1 has been shown to reduce Aβ in animal studies and in human trials. While BACE1 inhibitors are currently being tested in clinical trials to treat AD patients, it is highly important to understand whether BACE1 inhibition will significantly impact cognitive functions in AD patients. This review summarizes the recent studies on BACE1 synaptic functions. This knowledge will help to guide the proper use of BACE1 inhibitors in AD therapy.</p>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Amyloid deposition</kwd>
<kwd>β-amyloid peptide</kwd>
<kwd>BACE1</kwd>
<kwd>Secretase</kwd>
<kwd>BACE1 substrates</kwd>
<kwd>Synaptic functions</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id>
<institution>National Institutes of Health</institution>
</institution-wrap>
</funding-source>
<award-id>NS074256</award-id>
<award-id>AG046929</award-id>
<award-id>MH103942</award-id>
<principal-award-recipient>
<name>
<surname>Yan</surname>
<given-names>Riqiang</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2017</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Background</title>
<p id="Par2">Alzheimer’s disease (AD) is an age-dependent chronic neurodegenerative disease that is characterized by the presence of amyloid deposition, neurofibrillary tangles, synaptic dysfunction, and neuronal cell death [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. The common effector of this neurodegenerative process is the excessive production or accumulation of β-amyloid (Aβ), which has several deleterious effects on synaptic activity [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]. For over 30 years, amyloid precursor protein (APP) has been a main target for investigating the progression of AD. Aβ is generated from APP through proteolysis in a two-step process: β-secretase, known as β-site APP cleaving enzyme 1 (BACE1), initiates the cleavage of APP to release the membrane-anchored C-terminal fragment, and then γ-secretase subsequently cleaves this fragment to excise Aβ in 40–43 amino acid sequences [<xref ref-type="bibr" rid="CR5">5</xref>]. These sequences form hydrophobic aggregates, which constitute the senile plaques in AD. Risk factors associated with development of AD pathology involve genetic predisposition (familial early-onset forms), allele forms of apolipoprotein E (i.e, ApoE-4 has the strongest impact), age, lifestyle, and converging evidence which suggests that many newly identified mutations are linked to altered APP processing leading to amyloidogenic pathogenesis [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>].</p>
<p id="Par3">BACE1 has been an important target for therapeutic intervention because of its indispensable role in the generation of Aβ [<xref ref-type="bibr" rid="CR8">8</xref>–<xref ref-type="bibr" rid="CR12">12</xref>]. However, BACE1 also functions as a housekeeping enzyme and is involved in the processing of many other proteins that are responsible for proper functioning of neuronal tissue [Fig. <xref ref-type="fig" rid="Fig1">1</xref>]. Hence, complete removal of BACE1 enzymatic activity could potentially cause unwanted side effects. The most relevant of these is the effect of BACE1 on synaptic functions, which are related to AD pathology. To this end, this review aims to summarize our knowledge associated with the beneficial and detrimental effects of BACE1 in synaptic functions so that we can have a clearer understanding of the synaptic regulation by BACE1. This understanding will ultimately be beneficial for finding an optimally effective strategy to provide BACE1 drugs to AD patients.<fig id="Fig1"><label>Fig. 1</label><caption><p>APP and non-APP BACE1 substrates and their effects on synaptic transmisssion</p></caption><graphic id="MO1" xlink:href="40035_2017_93_Fig1_HTML"></graphic></fig>
</p>
</sec>
<sec id="Sec2">
<title>Pathophysiology of AD and synaptic deficiencies</title>
<p id="Par4">AD, along with stroke, is the third most common disease affecting the US population, afflicting ~7% of individuals ages 65–74, 53% at ages 75–84, and 40% at ages 85 and older, respectively [<xref ref-type="bibr" rid="CR13">13</xref>]. Worldwide, it affects nearly 44 million people and is one of major causes of age-dependent disability [<xref ref-type="bibr" rid="CR14">14</xref>]. With no definitive cure or treatment course in sight, the global cost of Alzheimer’s and dementia is estimated to be $605 billion. The pathological characteristics of AD present as cortical atrophy, neuro-inflammation, neuronal cell death, loss of synaptic connections, and the accumulation of neurofibrillary tangles and senile plaques [<xref ref-type="bibr" rid="CR15">15</xref>].</p>
<p id="Par5">The exact cause of AD is still unknown; however, genetic mutations in APP, presenilin 1 (PS1), or presenilin 2 (PS2) have been shown to promote the formation of amyloid plaques, which are a hallmark of AD pathology [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. The apolipoprotein E (ApoE) gene encodes three isoforms: ApoE2, ApoE3, and ApoE4. The ApoE4 isoform is identified as a genetic risk factor for late-onset AD because of its impact on the clearance of Aβ and amyloid deposition [<xref ref-type="bibr" rid="CR18">18</xref>–<xref ref-type="bibr" rid="CR21">21</xref>]. ApoE can also impact Aβ accumulation through its receptor, as ApoE receptor knockout mice have shown to increase Aß accumulation due to reduced clearance [<xref ref-type="bibr" rid="CR22">22</xref>].</p>
<p id="Par6">On the other hand, some AD risk genes are also involved in synaptic plasticity; loss of synaptic function in AD is evident long before any substantial loss of neurons [<xref ref-type="bibr" rid="CR23">23</xref>]. PS1 is a component in the synaptic junction [<xref ref-type="bibr" rid="CR24">24</xref>] and has been shown to regulate calcium homeostasis and the release of certain neurotransmitters [<xref ref-type="bibr" rid="CR25">25</xref>–<xref ref-type="bibr" rid="CR28">28</xref>]. An AD mouse model with a PS1 mutation also exhibits disruption in homeostatic scaling, a mechanism for preventing groups of neurons from altering their firing patterns too drastically in response to changes in the environment [<xref ref-type="bibr" rid="CR29">29</xref>]. ApoE may also regulate synaptic functions through its receptor, ApoE receptor 2 (ApoER2), which is known to promote synaptic plasticity and memory formation in mice [<xref ref-type="bibr" rid="CR30">30</xref>]. Toxic soluble Aß can also be directly cleared from the synapse via ApoE receptors [<xref ref-type="bibr" rid="CR31">31</xref>]. In mouse models, ApoER2 increases the number of dendritic spines and synapses and stabilizes them by regulating the assembly of a complex of proteins involved in synaptic terminals across neurons, a process which is important for learning and memory [<xref ref-type="bibr" rid="CR32">32</xref>]. In spite of the association of these proteins with synaptic functions, the effect of these genetic mutations on AD cognitive dysfunction remains to be fully established.</p>
<p id="Par7">Growing numbers of studies suggest that Aβ is likely to be the early effector molecule in AD cognitive dysfunction [see reviews [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR34">34</xref>]. Although the precise biochemical mechanisms underlying how variously assembled forms of Aβ cause synaptic dysfunction remain to be determined, biochemical and morphological studies have shown accumulation of Aβ at the synaptic terminals [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR36">36</xref>]. This local accumulation is likely attributable to the fact that BACE1 initiates the generation of Aβ at the synaptic terminals [<xref ref-type="bibr" rid="CR37">37</xref>]. Elevated levels of BCE1 have been directly correlated with Aβ-induced pathology in AD brains [<xref ref-type="bibr" rid="CR38">38</xref>–<xref ref-type="bibr" rid="CR40">40</xref>]. Increased amyloidogenic processing at the expense of nonamyloidogenic processing promotes Aβ accumulation at synapses in AD.</p>
<p id="Par8">On the other hand, many scaffolding proteins like mGluR proteins, Shank, Homer, and postsynaptic density 95 (PSD95) are known to form complexes at synaptic terminals, and Aβ accumulation at synaptic terminals leads to disruption of these scaffolding protein interactions, resulting in morphological and physiological alterations such as thinning of the synaptic terminals, alteration in the molecular composition of the PSD, and disruption of synaptic signaling pathways [<xref ref-type="bibr" rid="CR41">41</xref>–<xref ref-type="bibr" rid="CR45">45</xref>]. Hence, abnormal accumulation of Aβ is largely considered to be toxic to synaptic functions at multiple levels.</p>
</sec>
<sec id="Sec3">
<title>Effects of BACE1 on synaptic functions</title>
<p id="Par9">BACE1 is indispensable for the generation of Aβ, as germline deletion of the BACE1 gene abolishes the generation of Aβ [<xref ref-type="bibr" rid="CR46">46</xref>–<xref ref-type="bibr" rid="CR48">48</xref>]. BACE1 is therefore a molecule that is directly linked to synaptic functions, at least through its effects on Aβ accumulation in cells and synapses. BACE1 is predominantly expressed in brain and is richly expressed by neurons [<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR49">49</xref>, <xref ref-type="bibr" rid="CR50">50</xref>]. Accumulation of BACE1 is observed in normal and dystrophic presynaptic terminals surrounding amyloid plaques in brains of AD mouse models and patients, likely causing a vicious cycle by increasing Aβ production near synapses. Because of this, inhibition of BACE1 is logically viewed to reduce Aβ-mediated synaptic dysfunctions and to be potentially beneficial to AD patients. Hence, BACE1 inhibitors are being developed and tested for treating AD patients [<xref ref-type="bibr" rid="CR51">51</xref>, <xref ref-type="bibr" rid="CR52">52</xref>].</p>
<p id="Par10">However, whether BACE1 inhibition causes any unwanted effects on synaptic function has also attracted significant attention. This knowledge is critical for understanding the efficacy of BACE1 inhibitors in AD patients. It has been shown that BACE1 is normally expressed in broad brain regions, with rich expression by hippocampal granule cells. BACE1 has been shown to play a critical role in synaptic development and plasticity through cleavage of its various substrates [<xref ref-type="bibr" rid="CR51">51</xref>, <xref ref-type="bibr" rid="CR53">53</xref>, <xref ref-type="bibr" rid="CR54">54</xref>]. The effects of BACE1 on synaptic functions are likely to be through multiple mechanisms, as discussed below.<list list-type="order"><list-item><p id="Par11">BACE1 deficiency alters synaptic plasticity in relation to APP cleavage: Long-term changes in the strength of synaptic transmission are the basis of memory formation. Any correlated activity in the pre- and postsynaptic compartments of a synapse in a repeated pattern either strengthens synaptic connections (long term potentiation; LTP) or conversely weakens them (long term depression; LTD) [<xref ref-type="bibr" rid="CR55">55</xref>]. High levels of Aβ disturbs the balance of reactive oxygen species (ROS) in synaptic boutons and can interfere with pre- and postsynaptic function, presumably by affecting NMDARs, presynaptic P/Q type Ca<sup>2+</sup> channels, and/or α7-nAChRs, and thus interrupting subsequent Ca<sup>2+</sup> signaling and leading to altered synaptic function [<xref ref-type="bibr" rid="CR56">56</xref>].</p><p id="Par12">Mice lacking the BACE1 gene show no β-secretase activity and thus have nearly abolished Aβ (Aβ40 and Aβ42) production in the brain compared to wild-type controls. A deletion of the BACE1 gene in mouse models of AD was able to rescue hippocampal-dependent memory deficits resulting from Aβ accumulation [<xref ref-type="bibr" rid="CR49">49</xref>] and to ameliorate impaired hippocampal cholinergic regulation of neuronal excitability [<xref ref-type="bibr" rid="CR57">57</xref>]. Alternatively, BACE1 cleavage of APP will also produce a 99-amino acid C-terminal fragment, referred to as βAPPc or APP-C99. This βAPPc has been shown to impair synaptic functions [<xref ref-type="bibr" rid="CR58">58</xref>]. BACE1 deficiency benefits AD patients likely through reducing this toxic fragment. These findings implicate that BACE1 may be a good therapeutic target for treating AD [<xref ref-type="bibr" rid="CR59">59</xref>, <xref ref-type="bibr" rid="CR60">60</xref>].</p><p id="Par13">However, recent research progress may suggest otherwise. Since BACE1 has normal physiological functions in synaptic transmission and plasticity in CA1 region of hippocampus, BACE1-null mice displays deficits in both synaptic transmission and plasticity at the hippocampal Schaffer collateral to CA1 synapses [<xref ref-type="bibr" rid="CR49">49</xref>, <xref ref-type="bibr" rid="CR61">61</xref>]. There is a significant increase in the pair pulse ratio (PPF) in BACE1-null mice when compared to wild-type [<xref ref-type="bibr" rid="CR49">49</xref>]. Because changes in PPF ratio have been attributed to alterations in presynaptic release probability [<xref ref-type="bibr" rid="CR62">62</xref>], the increased PPF ratio seen in BACE1-null mice may indicate a deficit in presynaptic release [<xref ref-type="bibr" rid="CR49">49</xref>]. Consistently, BACE1-null mice display altered synaptic plasticity in CA1 and CA3 regions [<xref ref-type="bibr" rid="CR49">49</xref>, <xref ref-type="bibr" rid="CR63">63</xref>]. In addition to presynaptic alterations, changes in PPF ratio can also be attributed to postsynaptic modifications, such as in the subunit composition of AMPA receptors (AMPARs) [<xref ref-type="bibr" rid="CR64">64</xref>]. Physiological concentrations of Aβ (in pM range) have been shown to facilitate synaptic plasticity [<xref ref-type="bibr" rid="CR65">65</xref>] and BACE1 deficiency will cause a remarkable reduction in Aβ. Such a loss of physiological levels of Aβ may also lead to synaptic deficits.</p></list-item><list-item><p id="Par14">BACE1 deficiency alters synaptic plasticity in relation to neuregulin-1 cleavage: An alternative possibility is that the synaptic dysfunctions in BACE1-null mice may arise from abnormal processing of substrates other than APP, i.e., neuregulin-1 (Nrg1) [<xref ref-type="bibr" rid="CR66">66</xref>–<xref ref-type="bibr" rid="CR68">68</xref>]. Nrg1 has a plethora of functions in the central and peripheral nervous systems, which include regulation of myelination, radial and tangential neuronal migration of glutamatergic and GABAergic neurons, and synaptic plasticity [<xref ref-type="bibr" rid="CR69">69</xref>]. To exert these functions, Nrg1 is required to be cleaved by membrane-anchored proteases, and BACE1 is one such protease. BACE1 deficiency reduces Nrg1 signaling activity and causes defects in these functions as manifested in BACE1-null mice [<xref ref-type="bibr" rid="CR70">70</xref>, <xref ref-type="bibr" rid="CR71">71</xref>].</p><p id="Par15">Many behaviors in animals with Nrg1 mutations exhibit a close resemblance to putative characteristics of schizophrenia, such as impaired pre-pulse inhibition, and spontaneous hyperactivity, which can be reversed by clozapine [<xref ref-type="bibr" rid="CR72">72</xref>]. Nrg1 and its signaling receptor, the ErbB4 receptor, have been identified as leading candidates for schizophrenia susceptibility genes [<xref ref-type="bibr" rid="CR73">73</xref>]. It has also been shown that Nrg1-ErbB4 signaling enhances excitatory synapse formation on interneurons and inhibitory synapse formation on pyramidal neurons [<xref ref-type="bibr" rid="CR74">74</xref>, <xref ref-type="bibr" rid="CR75">75</xref>]. Specifically, deletion of ErbB4 from fast-spiking interneurons, such as chandelier and basket cells, has been shown to cause relatively subtle but consistent synaptic defects [<xref ref-type="bibr" rid="CR74">74</xref>]. Deletion of ErbB4 in interneurons increases miniature excitatory postsynaptic current (mEPSC) frequency and amplitude, but increases miniature inhibitory postsynaptic current frequency in pyramidal neurons [<xref ref-type="bibr" rid="CR75">75</xref>, <xref ref-type="bibr" rid="CR76">76</xref>]. In addition, Nrg1 increases both the number and size of PSD-95 puncta, indicating that Nrg1 stimulates the formation of new synapses and strengthens existing synapses. Nrg1 could also stimulate the stability of PSD-95 in a manner that requires tyrosine kinase activity of ErbB4 [<xref ref-type="bibr" rid="CR77">77</xref>]. Together, these results suggest that Nrg1 plays a significant role in excitatory synapse development, possibly via stabilizing PSD-95 [<xref ref-type="bibr" rid="CR76">76</xref>]. By abolishing Nrg1 cleavage to reduce Nrg1-ErbB4 signaling in synapses, BACE1 deficiency likely contributes to synaptic dysfunctions as reported in BACE1-null mice discussed above.</p></list-item><list-item><p id="Par16">BACE1 deficiency alters synaptic plasticity in relation to Sez6 cleavage: Another family of proteins, the seizure-related gene 6 (Sez6) and its family member Sez6L, were identified as BACE1 substrates through an unbiased proteomic approach and were recently validated as strong substrates of BACE1 [<xref ref-type="bibr" rid="CR78">78</xref>]. Sez6 and Sez6-like (Sez6L) are nearly exclusively cleaved by BACE1 and not by other proteases in the brain and are guided by their sub-cellular location and their function. They share an NPxY motif and a phosphotyrosine-binding domain (PTB) with another BACE1 substrate, amyloid precursor protein (APP). In BACE1-null and BACE1/2-double-null mice, a marked reduction in the shedding of Sez6 and Sez6L proteins has been confirmed. Their levels in BACE1-null cerebrospinal fluid (CSF) are significantly reduced to ~10% of the wild-type condition. Although the exact molecular functions of Sez6 and Sez6L are not yet fully understood, homology in their protein-binding domains to other cell surface receptors suggests that they may act as receptors at the cell surface [<xref ref-type="bibr" rid="CR79">79</xref>], as they were originally identified as membrane proteins with five copies of short consensus repeat with a complement C3b/C4b binding site and were seen to be elevated after bursts of neuronal activity [<xref ref-type="bibr" rid="CR80">80</xref>]. The interaction domains suggest adhesive and/or receptor trafficking functions of these proteins; however, their binding partners are not yet known. Sez-6 is required for normal dendritic arborization of cortical neurons, which is critical for neuronal transfer of information. Its localization along developing and mature dendritic branches and in dendritic spines modulates branch stability. In the absence of Sez-6, mice exhibit short dendrites while cultured cortical neurons display excessive neurite branching. Despite the noticeable effect on branching of dendrites, no obvious effect on an overall growth of the dendritic arbor is reported [<xref ref-type="bibr" rid="CR81">81</xref>]. Excessive dendritic branching does not always mean a better condition for synapse formation, as studies have found that postsynaptic specializations on these branches (labeled with PSD-95) were dramatically reduced [<xref ref-type="bibr" rid="CR82">82</xref>]. In the absence of Sez-6, spine numbers are reduced, with reduced excitatory synaptic connectivity between layers II/III and layer V pyramidal neurons in Sez-6-null mice. As spontaneous miniature EPSCs (mEPSCs) or EPSCs with minimal stimulation were not altered, the reduction might be because of uncoupling of pre- and postsynaptic ends of synapses due to altered branching patterns. There is also evidence for reduced synaptic density, punctate staining of PSD-95, and LTP in the frontal cortex of Sez6-null mice. Sez-6 proteins are therefore important for specifying proper dendritic arborization and for development of excitatory synapses on cortical neurons [<xref ref-type="bibr" rid="CR81">81</xref>]. There is an activity-driven up-regulation of Sez-6 expression after 2 h post-high frequency stimulation [<xref ref-type="bibr" rid="CR83">83</xref>]. Sez-6 expression levels are highly enriched in brain regions associated with ongoing morphological plasticity, such as the hippocampus and cerebellum in postnatal brain. In Sez-6 deficiency, animals exhibit poor motor coordination and balance, suppressed activity in the open field, reduced anxiety, as well as cognitive deficits. Thus Sez6 protein signaling is critical for excitatory synapse development and function [<xref ref-type="bibr" rid="CR81">81</xref>] and synaptic circuit refinement [<xref ref-type="bibr" rid="CR84">84</xref>]. Besides synapse formation and maintenance, Sez6 family members are also expressed and cleaved in lungs and pancreas [<xref ref-type="bibr" rid="CR79">79</xref>, <xref ref-type="bibr" rid="CR85">85</xref>]. Since Sez6 and Sez6L are exclusive substrates of BACE1, they can be used as a direct readout for BACE1 activity in CSF and as a control condition where BACE1 inhibitors can be developed in a substrate-specific manner (for APP) without hampering the physiological actions of BACE1 on other essential proteins like Sez6 that are critical for proper synchronous synaptic transmission.</p></list-item><list-item><p id="Par17">BACE1 deficiency alters synaptic plasticity in relation to jagged cleavage: Jagged-1 (Jag1) has been identified as a BACE1 substrate [<xref ref-type="bibr" rid="CR86">86</xref>] and is known to play important roles in neural development and synaptic functions. Jag1 regulates astrogenesis/neurogenesis via the Notch signaling pathway [<xref ref-type="bibr" rid="CR87">87</xref>–<xref ref-type="bibr" rid="CR89">89</xref>]. Because of abrogated Jag1 cleavage, BACE1-null mice exhibit increased astrogenesis and reduced neurogenesis due to increased Jag1-Notch interactions [<xref ref-type="bibr" rid="CR87">87</xref>]. This is consistent with a prior report that astrocytes negatively regulate neurogenesis through the Notch pathway [<xref ref-type="bibr" rid="CR90">90</xref>]. Although Notch and its ligands are expressed at low levels in the adult brain [<xref ref-type="bibr" rid="CR91">91</xref>, <xref ref-type="bibr" rid="CR92">92</xref>], they are needed for long-term memory, which is dependent on ultra-structural remodeling of synapses. Hence Notch has an important role in the neural plasticity underlying consolidated memory. Loss of Notch function produces memory deficits in <italic>Drosophila melanogaster</italic> [<xref ref-type="bibr" rid="CR93">93</xref>] and impairs proper morphology of dendritic spines [<xref ref-type="bibr" rid="CR91">91</xref>] in the mouse hippocampus. Thus Jag, as a Notch regulator, is important for synaptic plasticity that contributes to memory formation.</p><p id="Par18">On the other hand, a shift in the balance between neurogenesis and astrogenesis in BACE1-null mice likely contributes to aberrant synaptic transmission. Astrocytes regulate synaptic function and plasticity in close association with synapses [<xref ref-type="bibr" rid="CR94">94</xref>]. They are involved in synaptogenesis as well as synapse function and elimination. This tight structural and functional partnership between the perisynaptic astrocytic process and the neuronal pre- and postsynaptic structures constitutes the “tripartite synapse” [<xref ref-type="bibr" rid="CR95">95</xref>]. Astrocyte processes enclose synapses and define functional domains by ensheathing neuronal somas, axons, dendrites, and synapses occupying non overlapping territories, and thus establish gradually independent domains which are also developmentally regulated [<xref ref-type="bibr" rid="CR96">96</xref>, <xref ref-type="bibr" rid="CR97">97</xref>]. This process of segregation, also known as astrocyte tiling, is thought to be regulated by “contact inhibition” between neighboring astrocytes and is crucial for normal functions of the nervous system because, in disease and post-injury conditions, astrocytes lose their tiling ability and display intermingled process morphology [<xref ref-type="bibr" rid="CR98">98</xref>]. Astrocytes have also been known to regulate glutamatergic postsynaptic strength by increasing the number and stabilizing of AMPAR and NMDAR at the postsynaptic end of synapses [<xref ref-type="bibr" rid="CR99">99</xref>]. Hence, BACE1 inhibition may impact synaptic functions due to an imbalance in total astrocytes and neurons.</p></list-item></list>
</p>
</sec>
<sec id="Sec4">
<title>Conclusion</title>
<p id="Par19">Since BACE1 is the rate-limiting enzyme in the amyloid cascade, it is considered to be one of the promising targets for AD therapy. A rare human mutation at the BACE1 cleavage site of APP has been identified, which results in a 40% decrease in Aβ production in vitro, a reduced propensity of Aβ to aggregate, a five- to seven-fold reduced risk of developing AD, and improved cognitive function in elderly subjects without AD [<xref ref-type="bibr" rid="CR100">100</xref>–<xref ref-type="bibr" rid="CR102">102</xref>]. Hence, BACE1 inhibition is likely to be beneficial to AD patients. However, caution should also be taken considering the role of BACE1 in synaptic plasticity. For example, the BACE1 inhibitor verubecestat (MK-8931) showed great promise in early human and animal trials [<xref ref-type="bibr" rid="CR103">103</xref>], but a recent announcement that Merck was stopping one of its trials suggested cause for concern. By better understanding the physiological and pathological functions of BACE1, anticipation and possible circumvention of mechanism-based side effects that may arise due to BACE1 inhibition can be accomplished. Decoding molecular mechanisms that underlie AD pathogenesis will help us to develop efficient therapeutic approaches to combat disease progression.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>Due to space limitations, not all related studies regarding BACE1 substrates in synaptic functions are cited, but many of these studies were discussed in reviews cited in this article.</p>
<sec id="FPar1">
<title>Funding</title>
<p id="Par20">R Yan is supported by grants (MH103942, NS074256 and AG046929) from the National Institutes of Health.</p>
</sec>
<sec id="FPar2">
<title>Availability of data and materials</title>
<p id="Par21">The authors encourages free citation of data or conclusions in this review article.</p>
</sec>
</ack>
<notes notes-type="author-contribution">
<title>Authors’ contributions</title>
<p>Both BD and RY wrote this review. Both authors read and approved the final manuscript.</p>
</notes>
<notes notes-type="COI-statement">
<sec id="FPar3">
<title>Ethics approval and consent to participate</title>
<p id="Par22">Not applicable.</p>
</sec>
<sec id="FPar4">
<title>Consent for publication</title>
<p id="Par23">Not applicable</p>
</sec>
<sec id="FPar5">
<title>Competing interests</title>
<p id="Par24">The authors declare that they have no competing interests.</p>
</sec>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Musiek</surname>
<given-names>ES</given-names>
</name>
<name>
<surname>Holtzman</surname>
<given-names>DM</given-names>
</name>
</person-group>
<article-title>Three dimensions of the amyloid hypothesis: time, space and ‘wingmen’</article-title>
<source/>Nat Neurosci
          <year>2015</year>
<volume>18</volume>
<issue>6</issue>
<fpage>800</fpage>
<lpage>806</lpage>
<pub-id pub-id-type="doi">10.1038/nn.4018</pub-id>
<pub-id pub-id-type="pmid">26007213</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Selkoe</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Hardy</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>The amyloid hypothesis of Alzheimer's disease at 25 years</article-title>
<source/>EMBO Mol Med
          <year>2016</year>
<volume>8</volume>
<issue>6</issue>
<fpage>595</fpage>
<lpage>608</lpage>
<pub-id pub-id-type="doi">10.15252/emmm.201606210</pub-id>
<pub-id pub-id-type="pmid">27025652</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Malenka</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Malinow</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Alzheimer's disease: recollection of lost memories</article-title>
<source/>Nature
          <year>2011</year>
<volume>469</volume>
<issue>7328</issue>
<fpage>44</fpage>
<lpage>45</lpage>
<pub-id pub-id-type="doi">10.1038/469044a</pub-id>
<pub-id pub-id-type="pmid">21209657</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yan</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Vassar</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Inhibiting BACE1 to reverse synaptic dysfunctions in Alzheimer's disease</article-title>
<source/>Neurosci Biobehav Rev
          <year>2016</year>
<volume>65</volume>
<fpage>326</fpage>
<lpage>340</lpage>
<pub-id pub-id-type="doi">10.1016/j.neubiorev.2016.03.025</pub-id>
<pub-id pub-id-type="pmid">27044452</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haass</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Take five--BACE and the gamma-secretase quartet conduct Alzheimer's amyloid beta-peptide generation</article-title>
<source/>EMBO J
          <year>2004</year>
<volume>23</volume>
<issue>3</issue>
<fpage>483</fpage>
<lpage>488</lpage>
<pub-id pub-id-type="doi">10.1038/sj.emboj.7600061</pub-id>
<pub-id pub-id-type="pmid">14749724</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karch</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Cruchaga</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Goate</surname>
<given-names>AM</given-names>
</name>
</person-group>
<article-title>Alzheimer's disease genetics: from the bench to the clinic</article-title>
<source/>Neuron
          <year>2014</year>
<volume>83</volume>
<issue>1</issue>
<fpage>11</fpage>
<lpage>26</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2014.05.041</pub-id>
<pub-id pub-id-type="pmid">24991952</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<mixed-citation publication-type="other">Tanzi RE. The genetics of Alzheimer disease. Cold Spring Harb Perspect Med. 2012;2(10) doi:10.1101/cshperspect.a006296</mixed-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hussain</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Powell</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Howlett</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Tew</surname>
<given-names>DG</given-names>
</name>
<name>
<surname>Meek</surname>
<given-names>TD</given-names>
</name>
<name>
<surname>Chapman</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Identification of a novel aspartic protease (asp 2) as beta-secretase</article-title>
<source/>Mol Cell Neurosci
          <year>1999</year>
<volume>14</volume>
<issue>6</issue>
<fpage>419</fpage>
<lpage>427</lpage>
<pub-id pub-id-type="doi">10.1006/mcne.1999.0811</pub-id>
<pub-id pub-id-type="pmid">10656250</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Koelsch</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Downs</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Dashti</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2000</year>
<volume>97</volume>
<issue>4</issue>
<fpage>1456</fpage>
<lpage>1460</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.97.4.1456</pub-id>
<pub-id pub-id-type="pmid">10677483</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sinha</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Barbour</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Basi</surname>
<given-names>GS</given-names>
</name>
<name>
<surname>Caccavello</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Purification and cloning of amyloid precursor protein beta-secretase from human brain</article-title>
<source/>Nature
          <year>1999</year>
<volume>402</volume>
<issue>6761</issue>
<fpage>537</fpage>
<lpage>540</lpage>
<pub-id pub-id-type="doi">10.1038/990114</pub-id>
<pub-id pub-id-type="pmid">10591214</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vassar</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>BD</given-names>
</name>
<name>
<surname>Babu-Khan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kahn</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mendiaz</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Denis</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE</article-title>
<source/>Science
          <year>1999</year>
<volume>286</volume>
<issue>5440</issue>
<fpage>735</fpage>
<lpage>741</lpage>
<pub-id pub-id-type="doi">10.1126/science.286.5440.735</pub-id>
<pub-id pub-id-type="pmid">10531052</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yan</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Bienkowski</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Shuck</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Miao</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Tory</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Pauley</surname>
<given-names>AM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity</article-title>
<source/>Nature
          <year>1999</year>
<volume>402</volume>
<issue>6761</issue>
<fpage>533</fpage>
<lpage>537</lpage>
<pub-id pub-id-type="doi">10.1038/990107</pub-id>
<pub-id pub-id-type="pmid">10591213</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hebert</surname>
<given-names>LE</given-names>
</name>
<name>
<surname>Scherr</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Bienias</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>DA</given-names>
</name>
</person-group>
<article-title>Alzheimer disease in the US population: prevalence estimates using the 2000 census</article-title>
<source/>Arch Neurol
          <year>2003</year>
<volume>60</volume>
<issue>8</issue>
<fpage>1119</fpage>
<lpage>1122</lpage>
<pub-id pub-id-type="doi">10.1001/archneur.60.8.1119</pub-id>
<pub-id pub-id-type="pmid">12925369</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alzheimer's</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>2016 Alzheimer's disease facts and figures</article-title>
<source/>Alzheimers Dement
          <year>2016</year>
<volume>12</volume>
<issue>4</issue>
<fpage>459</fpage>
<lpage>509</lpage>
<pub-id pub-id-type="doi">10.1016/j.jalz.2016.03.001</pub-id>
<pub-id pub-id-type="pmid">27570871</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holtzman</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Goate</surname>
<given-names>AM</given-names>
</name>
</person-group>
<article-title>Alzheimer’s disease: the challenge of the second century</article-title>
<source/>Sci Transl Med
          <year>2011</year>
<volume>3</volume>
<issue>77</issue>
<fpage>77sr71</fpage>
<pub-id pub-id-type="doi">10.1126/scitranslmed.3002369</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Strooper</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Iwatsubo</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Wolfe</surname>
<given-names>MS</given-names>
</name>
</person-group>
<article-title>Presenilins and gamma-secretase: structure, function, and role in Alzheimer disease</article-title>
<source/>Cold Spring Harb Perspect Med
          <year>2012</year>
<volume>2</volume>
<issue>1</issue>
<fpage>a006304</fpage>
<pub-id pub-id-type="doi">10.1101/cshperspect.a006304</pub-id>
<pub-id pub-id-type="pmid">22315713</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Bohm</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Dodd</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Qamar</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Schmitt-Ulms</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Structural biology of presenilin 1 complexes</article-title>
<source/>Mol Neurodegener
          <year>2014</year>
<volume>9</volume>
<fpage>59</fpage>
<pub-id pub-id-type="doi">10.1186/1750-1326-9-59</pub-id>
<pub-id pub-id-type="pmid">25523933</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Kanekiyo</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Bu</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy</article-title>
<source/>Nat Rev Neurol
          <year>2013</year>
<volume>9</volume>
<issue>2</issue>
<fpage>106</fpage>
<lpage>118</lpage>
<pub-id pub-id-type="doi">10.1038/nrneurol.2012.263</pub-id>
<pub-id pub-id-type="pmid">23296339</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saunders</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Schmader</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Breitner</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Benson</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>WT</given-names>
</name>
<name>
<surname>Goldfarb</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases</article-title>
<source/>Lancet
          <year>1993</year>
<volume>342</volume>
<issue>8873</issue>
<fpage>710</fpage>
<lpage>711</lpage>
<pub-id pub-id-type="doi">10.1016/0140-6736(93)91709-U</pub-id>
<pub-id pub-id-type="pmid">8103823</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Strittmatter</surname>
<given-names>WJ</given-names>
</name>
<name>
<surname>Saunders</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Schmechel</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Pericak-Vance</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Enghild</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Salvesen</surname>
<given-names>GS</given-names>
</name>
<name>
<surname>Roses</surname>
<given-names>AD</given-names>
</name>
</person-group>
<article-title>Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>1993</year>
<volume>90</volume>
<issue>5</issue>
<fpage>1977</fpage>
<lpage>1981</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.90.5.1977</pub-id>
<pub-id pub-id-type="pmid">8446617</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holtzman</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Herz</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bu</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease</article-title>
<source/>Cold Spring Harb Perspect Med
          <year>2012</year>
<volume>2</volume>
<issue>3</issue>
<fpage>a006312</fpage>
<pub-id pub-id-type="doi">10.1101/cshperspect.a006312</pub-id>
<pub-id pub-id-type="pmid">22393530</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shibata</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yamada</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Calero</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bading</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Frangione</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier</article-title>
<source/>J Clin Invest
          <year>2000</year>
<volume>106</volume>
<issue>12</issue>
<fpage>1489</fpage>
<lpage>1499</lpage>
<pub-id pub-id-type="doi">10.1172/JCI10498</pub-id>
<pub-id pub-id-type="pmid">11120756</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Selkoe</surname>
<given-names>DJ</given-names>
</name>
</person-group>
<article-title>Alzheimer's disease is a synaptic failure</article-title>
<source/>Science
          <year>2002</year>
<volume>298</volume>
<issue>5594</issue>
<fpage>789</fpage>
<lpage>791</lpage>
<pub-id pub-id-type="doi">10.1126/science.1074069</pub-id>
<pub-id pub-id-type="pmid">12399581</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Georgakopoulos</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Marambaud</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Efthimiopoulos</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Shioi</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>HC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Presenilin-1 forms complexes with the cadherin/catenin cell-cell adhesion system and is recruited to intercellular and synaptic contacts</article-title>
<source/>Mol Cell
          <year>1999</year>
<volume>4</volume>
<issue>6</issue>
<fpage>893</fpage>
<lpage>902</lpage>
<pub-id pub-id-type="doi">10.1016/S1097-2765(00)80219-1</pub-id>
<pub-id pub-id-type="pmid">10635315</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bezprozvanny</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Hiesinger</surname>
<given-names>PR</given-names>
</name>
</person-group>
<article-title>The synaptic maintenance problem: membrane recycling, Ca2+ homeostasis and late onset degeneration</article-title>
<source/>Mol Neurodegener
          <year>2013</year>
<volume>8</volume>
<fpage>23</fpage>
<pub-id pub-id-type="doi">10.1186/1750-1326-8-23</pub-id>
<pub-id pub-id-type="pmid">23829673</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ho</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Presenilins in synaptic function and disease</article-title>
<source/>Trends Mol Med
          <year>2011</year>
<volume>17</volume>
<issue>11</issue>
<fpage>617</fpage>
<lpage>624</lpage>
<pub-id pub-id-type="doi">10.1016/j.molmed.2011.06.002</pub-id>
<pub-id pub-id-type="pmid">21795114</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mattson</surname>
<given-names>MP</given-names>
</name>
</person-group>
<article-title>ER calcium and Alzheimer's disease: in a state of flux</article-title>
<source/>Sci Signal
          <year>2010</year>
<volume>3</volume>
<issue>114</issue>
<fpage>pe10</fpage>
<pub-id pub-id-type="doi">10.1126/scisignal.3114pe10</pub-id>
<pub-id pub-id-type="pmid">20332425</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kazim</surname>
<given-names>SF</given-names>
</name>
<name>
<surname>Iqbal</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Neurotrophic factor small-molecule mimetics mediated neuroregeneration and synaptic repair: emerging therapeutic modality for Alzheimer's disease</article-title>
<source/>Mol Neurodegener
          <year>2016</year>
<volume>11</volume>
<issue>1</issue>
<fpage>50</fpage>
<pub-id pub-id-type="doi">10.1186/s13024-016-0119-y</pub-id>
<pub-id pub-id-type="pmid">27400746</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pratt</surname>
<given-names>KG</given-names>
</name>
<name>
<surname>Zimmerman</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Cook</surname>
<given-names>DG</given-names>
</name>
<name>
<surname>Sullivan</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>Presenilin 1 regulates homeostatic synaptic scaling through Akt signaling</article-title>
<source/>Nat Neurosci
          <year>2011</year>
<volume>14</volume>
<issue>9</issue>
<fpage>1112</fpage>
<lpage>1114</lpage>
<pub-id pub-id-type="doi">10.1038/nn.2893</pub-id>
<pub-id pub-id-type="pmid">21841774</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wasser</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Masiulis</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Durakoglugil</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Lane-Donovan</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Xian</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Beffert</surname>
<given-names>U</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Differential splicing and glycosylation of Apoer2 alters synaptic plasticity and fear learning</article-title>
<source/>Sci Signal
          <year>2014</year>
<volume>7</volume>
<issue>353</issue>
<fpage>ra113</fpage>
<pub-id pub-id-type="doi">10.1126/scisignal.2005438</pub-id>
<pub-id pub-id-type="pmid">25429077</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gylys</surname>
<given-names>KH</given-names>
</name>
<name>
<surname>Fein</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Cole</surname>
<given-names>GM</given-names>
</name>
</person-group>
<article-title>Apolipoprotein E enhances uptake of soluble but not aggregated amyloid-beta protein into synaptic terminals</article-title>
<source/>J Neurochem
          <year>2003</year>
<volume>84</volume>
<issue>6</issue>
<fpage>1442</fpage>
<lpage>1451</lpage>
<pub-id pub-id-type="doi">10.1046/j.1471-4159.2003.01643.x</pub-id>
<pub-id pub-id-type="pmid">12614344</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dumanis</surname>
<given-names>SB</given-names>
</name>
<name>
<surname>Cha</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Trotter</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Spitzer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>JY</given-names>
</name>
<etal></etal>
</person-group>
<article-title>ApoE receptor 2 regulates synapse and dendritic spine formation</article-title>
<source/>PLoS One
          <year>2011</year>
<volume>6</volume>
<issue>2</issue>
<fpage>e17203</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0017203</pub-id>
<pub-id pub-id-type="pmid">21347244</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Forner</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Baglietto-Vargas</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Martini</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Trujillo-Estrada</surname>
<given-names>L</given-names>
</name>
<name>
<surname>LaFerla</surname>
<given-names>FM</given-names>
</name>
</person-group>
<article-title>Synaptic impairment in Alzheimer's disease: a Dysregulated symphony</article-title>
<source/>Trends Neurosci
          <year>2017</year>
<volume>40</volume>
<issue>6</issue>
<fpage>347</fpage>
<lpage>357</lpage>
<pub-id pub-id-type="doi">10.1016/j.tins.2017.04.002</pub-id>
<pub-id pub-id-type="pmid">28494972</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Okamoto</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lipton</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Oligomeric Abeta-induced synaptic dysfunction in Alzheimer's disease</article-title>
<source/>Mol Neurodegener
          <year>2014</year>
<volume>9</volume>
<fpage>48</fpage>
<pub-id pub-id-type="doi">10.1186/1750-1326-9-48</pub-id>
<pub-id pub-id-type="pmid">25394486</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Audrain</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Fol</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Dutar</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Potier</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Billard</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Flament</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Alzheimer's disease-like APP processing in wild-type mice identifies synaptic defects as initial steps of disease progression</article-title>
<source/>Mol Neurodegener
          <year>2016</year>
<volume>11</volume>
<fpage>5</fpage>
<pub-id pub-id-type="doi">10.1186/s13024-016-0070-y</pub-id>
<pub-id pub-id-type="pmid">26759118</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coleman</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Federoff</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kurlan</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>A focus on the synapse for neuroprotection in Alzheimer disease and other dementias</article-title>
<source/>Neurology
          <year>2004</year>
<volume>63</volume>
<issue>7</issue>
<fpage>1155</fpage>
<lpage>1162</lpage>
<pub-id pub-id-type="doi">10.1212/01.WNL.0000140626.48118.0A</pub-id>
<pub-id pub-id-type="pmid">15477531</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kandalepas</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Sadleir</surname>
<given-names>KR</given-names>
</name>
<name>
<surname>Eimer</surname>
<given-names>WA</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Nicholson</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Vassar</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>The Alzheimer's beta-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques</article-title>
<source/>Acta Neuropathol
          <year>2013</year>
<volume>126</volume>
<issue>3</issue>
<fpage>329</fpage>
<lpage>352</lpage>
<pub-id pub-id-type="doi">10.1007/s00401-013-1152-3</pub-id>
<pub-id pub-id-type="pmid">23820808</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fukumoto</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Cheung</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Hyman</surname>
<given-names>BT</given-names>
</name>
<name>
<surname>Irizarry</surname>
<given-names>MC</given-names>
</name>
</person-group>
<article-title>Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease</article-title>
<source/>Arch Neurol
          <year>2002</year>
<volume>59</volume>
<issue>9</issue>
<fpage>1381</fpage>
<lpage>1389</lpage>
<pub-id pub-id-type="doi">10.1001/archneur.59.9.1381</pub-id>
<pub-id pub-id-type="pmid">12223024</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holsinger</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>McLean</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Beyreuther</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Masters</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Evin</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Increased expression of the amyloid precursor beta-secretase in Alzheimer's disease</article-title>
<source/>Ann Neurol
          <year>2002</year>
<volume>51</volume>
<issue>6</issue>
<fpage>783</fpage>
<lpage>786</lpage>
<pub-id pub-id-type="doi">10.1002/ana.10208</pub-id>
<pub-id pub-id-type="pmid">12112088</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>LB</given-names>
</name>
<name>
<surname>Lindholm</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Citron</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>XL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease</article-title>
<source/>Nat Med
          <year>2003</year>
<volume>9</volume>
<issue>1</issue>
<fpage>3</fpage>
<lpage>4</lpage>
<pub-id pub-id-type="doi">10.1038/nm0103-3</pub-id>
<pub-id pub-id-type="pmid">12514700</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Almeida</surname>
<given-names>CG</given-names>
</name>
<name>
<surname>Tampellini</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>RH</given-names>
</name>
<name>
<surname>Greengard</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Snyder</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Gouras</surname>
<given-names>GK</given-names>
</name>
</person-group>
<article-title>Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses</article-title>
<source/>Neurobiol Dis
          <year>2005</year>
<volume>20</volume>
<issue>2</issue>
<fpage>187</fpage>
<lpage>198</lpage>
<pub-id pub-id-type="doi">10.1016/j.nbd.2005.02.008</pub-id>
<pub-id pub-id-type="pmid">16242627</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roselli</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Hutzler</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Wegerich</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Livrea</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Almeida</surname>
<given-names>OF</given-names>
</name>
</person-group>
<article-title>Disassembly of shank and homer synaptic clusters is driven by soluble beta-amyloid(1-40) through divergent NMDAR-dependent signalling pathways</article-title>
<source/>PLoS One
          <year>2009</year>
<volume>4</volume>
<issue>6</issue>
<fpage>e6011</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0006011</pub-id>
<pub-id pub-id-type="pmid">19547699</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roselli</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Tirard</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hutzler</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Lamberti</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Livrea</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Soluble beta-amyloid1-40 induces NMDA-dependent degradation of postsynaptic density-95 at glutamatergic synapses</article-title>
<source/>J Neurosci
          <year>2005</year>
<volume>25</volume>
<issue>48</issue>
<fpage>11061</fpage>
<lpage>11070</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.3034-05.2005</pub-id>
<pub-id pub-id-type="pmid">16319306</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>LW</given-names>
</name>
<name>
<surname>Berry-Kravis</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Hagerman</surname>
<given-names>RJ</given-names>
</name>
</person-group>
<article-title>Fragile X: leading the way for targeted treatments in autism</article-title>
<source/>Neurotherapeutics
          <year>2010</year>
<volume>7</volume>
<issue>3</issue>
<fpage>264</fpage>
<lpage>274</lpage>
<pub-id pub-id-type="doi">10.1016/j.nurt.2010.05.005</pub-id>
<pub-id pub-id-type="pmid">20643379</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Golovyashkina</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Penazzi</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ballatore</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>AB</given-names>
<suffix>3rd</suffix>
</name>
<name>
<surname>Bakota</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Brandt</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Region-specific dendritic simplification induced by Abeta, mediated by tau via dysregulation of microtubule dynamics: a mechanistic distinct event from other neurodegenerative processes</article-title>
<source/>Mol Neurodegener
          <year>2015</year>
<volume>10</volume>
<fpage>60</fpage>
<pub-id pub-id-type="doi">10.1186/s13024-015-0049-0</pub-id>
<pub-id pub-id-type="pmid">26541821</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cai</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>McCarthy</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Wen</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Borchelt</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Price</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>PC</given-names>
</name>
</person-group>
<article-title>BACE1 is the major beta-secretase for generation of Abeta peptides by neurons</article-title>
<source/>Nat Neurosci
          <year>2001</year>
<volume>4</volume>
<issue>3</issue>
<fpage>233</fpage>
<lpage>234</lpage>
<pub-id pub-id-type="doi">10.1038/85064</pub-id>
<pub-id pub-id-type="pmid">11224536</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luo</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Bolon</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Kahn</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>BD</given-names>
</name>
<name>
<surname>Babu-Khan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Denis</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation</article-title>
<source/>Nat Neurosci
          <year>2001</year>
<volume>4</volume>
<issue>3</issue>
<fpage>231</fpage>
<lpage>232</lpage>
<pub-id pub-id-type="doi">10.1038/85059</pub-id>
<pub-id pub-id-type="pmid">11224535</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<mixed-citation publication-type="other">Roberds SL, Anderson J, Basi G, Bienkowski MJ, Branstetter DG, Chen KS, McConlogue L. BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics. Hum Mol Genet. 2001;10(12):1317–1324.</mixed-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laird</surname>
<given-names>FM</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Savonenko</surname>
<given-names>AV</given-names>
</name>
<name>
<surname>Farah</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>He</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Melnikova</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>BACE1, a major determinant of selective vulnerability of the brain to amyloid-beta amyloidogenesis, is essential for cognitive, emotional, and synaptic functions</article-title>
<source/>J Neurosci
          <year>2005</year>
<volume>25</volume>
<issue>50</issue>
<fpage>11693</fpage>
<lpage>11709</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2766-05.2005</pub-id>
<pub-id pub-id-type="pmid">16354928</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yasvoina</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Shao</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Hitt</surname>
<given-names>B</given-names>
</name>
<name>
<surname>O'Connor</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Beta-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer's disease pathogenesis</article-title>
<source/>J Neurosci
          <year>2007</year>
<volume>27</volume>
<issue>14</issue>
<fpage>3639</fpage>
<lpage>3649</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.4396-06.2007</pub-id>
<pub-id pub-id-type="pmid">17409228</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vassar</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Kuhn</surname>
<given-names>PH</given-names>
</name>
<name>
<surname>Haass</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kennedy</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Rajendran</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Lichtenthaler</surname>
<given-names>SF</given-names>
</name>
</person-group>
<article-title>Function, therapeutic potential and cell biology of BACE proteases: current status and future prospects</article-title>
<source/>J Neurochem
          <year>2014</year>
<volume>130</volume>
<issue>1</issue>
<fpage>4</fpage>
<lpage>28</lpage>
<pub-id pub-id-type="doi">10.1111/jnc.12715</pub-id>
<pub-id pub-id-type="pmid">24646365</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yan</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Stepping closer to treating Alzheimer's disease patients with BACE1 inhibitor drugs</article-title>
<source/>Transl Neurodegener
          <year>2016</year>
<volume>5</volume>
<fpage>13</fpage>
<pub-id pub-id-type="doi">10.1186/s40035-016-0061-5</pub-id>
<pub-id pub-id-type="pmid">27418961</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yan</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Physiological functions of the beta-site Amyloid precursor protein cleaving enzyme 1 and 2</article-title>
<source/>Front Mol Neurosci
          <year>2017</year>
<volume>10</volume>
<fpage>97</fpage>
<pub-id pub-id-type="pmid">28469554</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yan</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Vassar</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Targeting the beta secretase BACE1 for Alzheimer's disease therapy</article-title>
<source/>Lancet Neurol
          <year>2014</year>
<volume>13</volume>
<issue>3</issue>
<fpage>319</fpage>
<lpage>329</lpage>
<pub-id pub-id-type="doi">10.1016/S1474-4422(13)70276-X</pub-id>
<pub-id pub-id-type="pmid">24556009</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morris</surname>
<given-names>RG</given-names>
</name>
</person-group>
<article-title>D.O. Hebb: the Organization of Behavior, Wiley: New York; 1949</article-title>
<source/>Brain Res Bull
          <year>1999</year>
<volume>50</volume>
<issue>5–6</issue>
<fpage>437</fpage>
<pub-id pub-id-type="doi">10.1016/S0361-9230(99)00182-3</pub-id>
<pub-id pub-id-type="pmid">10643472</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Megill</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Kirkwood</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>HK</given-names>
</name>
</person-group>
<article-title>Postsynaptic target specific synaptic dysfunctions in the CA3 area of BACE1 knockout mice</article-title>
<source/>PLoS One
          <year>2014</year>
<volume>9</volume>
<issue>3</issue>
<fpage>e92279</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0092279</pub-id>
<pub-id pub-id-type="pmid">24637500</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ohno</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sametsky</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Younkin</surname>
<given-names>LH</given-names>
</name>
<name>
<surname>Oakley</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Younkin</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Citron</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer's disease</article-title>
<source/>Neuron
          <year>2004</year>
<volume>41</volume>
<issue>1</issue>
<fpage>27</fpage>
<lpage>33</lpage>
<pub-id pub-id-type="doi">10.1016/S0896-6273(03)00810-9</pub-id>
<pub-id pub-id-type="pmid">14715132</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tamayev</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Matsuda</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Arancio</surname>
<given-names>O</given-names>
</name>
<name>
<surname>D'Adamio</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Beta- but not gamma-secretase proteolysis of APP causes synaptic and memory deficits in a mouse model of dementia</article-title>
<source/>EMBO Mol Med
          <year>2012</year>
<volume>4</volume>
<issue>3</issue>
<fpage>171</fpage>
<lpage>179</lpage>
<pub-id pub-id-type="doi">10.1002/emmm.201100195</pub-id>
<pub-id pub-id-type="pmid">22170863</pub-id>
</element-citation>
</ref>
<ref id="CR59">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Citron</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Strategies for disease modification in Alzheimer's disease</article-title>
<source/>Nat Rev Neurosci
          <year>2004</year>
<volume>5</volume>
<issue>9</issue>
<fpage>677</fpage>
<lpage>685</lpage>
<pub-id pub-id-type="doi">10.1038/nrn1495</pub-id>
<pub-id pub-id-type="pmid">15322526</pub-id>
</element-citation>
</ref>
<ref id="CR60">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vassar</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Beta-secretase (BACE) as a drug target for Alzheimer's disease</article-title>
<source/>Adv Drug Deliv Rev
          <year>2002</year>
<volume>54</volume>
<issue>12</issue>
<fpage>1589</fpage>
<lpage>1602</lpage>
<pub-id pub-id-type="doi">10.1016/S0169-409X(02)00157-6</pub-id>
<pub-id pub-id-type="pmid">12453676</pub-id>
</element-citation>
</ref>
<ref id="CR61">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dominguez</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Tournoy</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hartmann</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Huth</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Cryns</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Deforce</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Phenotypic and biochemical analyses of BACE1- and BACE2-deficient mice</article-title>
<source/>J Biol Chem
          <year>2005</year>
<volume>280</volume>
<issue>35</issue>
<fpage>30797</fpage>
<lpage>30806</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M505249200</pub-id>
<pub-id pub-id-type="pmid">15987683</pub-id>
</element-citation>
</ref>
<ref id="CR62">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manabe</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Wyllie</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Perkel</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Nicoll</surname>
<given-names>RA</given-names>
</name>
</person-group>
<article-title>Modulation of synaptic transmission and long-term potentiation: effects on paired pulse facilitation and EPSC variance in the CA1 region of the hippocampus</article-title>
<source/>J Neurophysiol
          <year>1993</year>
<volume>70</volume>
<issue>4</issue>
<fpage>1451</fpage>
<lpage>1459</lpage>
<pub-id pub-id-type="pmid">7904300</pub-id>
</element-citation>
</ref>
<ref id="CR63">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Laird</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>HK</given-names>
</name>
</person-group>
<article-title>BACE1 knock-outs display deficits in activity-dependent potentiation of synaptic transmission at mossy fiber to CA3 synapses in the hippocampus</article-title>
<source/>J Neurosci
          <year>2008</year>
<volume>28</volume>
<issue>35</issue>
<fpage>8677</fpage>
<lpage>8681</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2440-08.2008</pub-id>
<pub-id pub-id-type="pmid">18753368</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rozov</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zilberter</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wollmuth</surname>
<given-names>LP</given-names>
</name>
<name>
<surname>Burnashev</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Facilitation of currents through rat Ca2+−permeable AMPA receptor channels by activity-dependent relief from polyamine block</article-title>
<source/>J Physiol
          <year>1998</year>
<volume>511</volume>
<issue>Pt 2</issue>
<fpage>361</fpage>
<lpage>377</lpage>
<pub-id pub-id-type="doi">10.1111/j.1469-7793.1998.361bh.x</pub-id>
<pub-id pub-id-type="pmid">9706016</pub-id>
</element-citation>
</ref>
<ref id="CR65">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Puzzo</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Privitera</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Leznik</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Fa</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Staniszewski</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Palmeri</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Arancio</surname>
<given-names>O</given-names>
</name>
</person-group>
<article-title>Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus</article-title>
<source/>J Neurosci
          <year>2008</year>
<volume>28</volume>
<issue>53</issue>
<fpage>14537</fpage>
<lpage>14545</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2692-08.2008</pub-id>
<pub-id pub-id-type="pmid">19118188</pub-id>
</element-citation>
</ref>
<ref id="CR66">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Neurological dysfunctions associated with altered BACE1-dependent Neuregulin-1 signaling</article-title>
<source/>J Neurochem
          <year>2016</year>
<volume>136</volume>
<issue>2</issue>
<fpage>234</fpage>
<lpage>249</lpage>
<pub-id pub-id-type="doi">10.1111/jnc.13395</pub-id>
<pub-id pub-id-type="pmid">26465092</pub-id>
</element-citation>
</ref>
<ref id="CR67">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fleck</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Garratt</surname>
<given-names>AN</given-names>
</name>
<name>
<surname>Haass</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Willem</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>BACE1 dependent neuregulin processing: review</article-title>
<source/>Curr Alzheimer Res
          <year>2012</year>
<volume>9</volume>
<issue>2</issue>
<fpage>178</fpage>
<lpage>183</lpage>
<pub-id pub-id-type="doi">10.2174/156720512799361637</pub-id>
<pub-id pub-id-type="pmid">22455478</pub-id>
</element-citation>
</ref>
<ref id="CR68">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Savonenko</surname>
<given-names>AV</given-names>
</name>
<name>
<surname>Melnikova</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Laird</surname>
<given-names>FM</given-names>
</name>
<name>
<surname>Stewart</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Price</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>PC</given-names>
</name>
</person-group>
<article-title>Alteration of BACE1-dependent NRG1/ErbB4 signaling and schizophrenia-like phenotypes in BACE1-null mice</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2008</year>
<volume>105</volume>
<issue>14</issue>
<fpage>5585</fpage>
<lpage>5590</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0710373105</pub-id>
<pub-id pub-id-type="pmid">18385378</pub-id>
</element-citation>
</ref>
<ref id="CR69">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mei</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Nave</surname>
<given-names>KA</given-names>
</name>
</person-group>
<article-title>Neuregulin-ERBB signaling in the nervous system and neuropsychiatric diseases</article-title>
<source/>Neuron
          <year>2014</year>
<volume>83</volume>
<issue>1</issue>
<fpage>27</fpage>
<lpage>49</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2014.06.007</pub-id>
<pub-id pub-id-type="pmid">24991953</pub-id>
</element-citation>
</ref>
<ref id="CR70">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Hicks</surname>
<given-names>CW</given-names>
</name>
<name>
<surname>He</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Macklin</surname>
<given-names>WB</given-names>
</name>
<name>
<surname>Trapp</surname>
<given-names>BD</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Bace1 modulates myelination in the central and peripheral nervous system</article-title>
<source/>Nat Neurosci
          <year>2006</year>
<volume>9</volume>
<issue>12</issue>
<fpage>1520</fpage>
<lpage>1525</lpage>
<pub-id pub-id-type="doi">10.1038/nn1797</pub-id>
<pub-id pub-id-type="pmid">17099708</pub-id>
</element-citation>
</ref>
<ref id="CR71">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fleck</surname>
<given-names>D</given-names>
</name>
<name>
<surname>van Bebber</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Colombo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Galante</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Schwenk</surname>
<given-names>BM</given-names>
</name>
<name>
<surname>Rabe</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Dual cleavage of neuregulin 1 type III by BACE1 and ADAM17 liberates its EGF-like domain and allows paracrine signaling</article-title>
<source/>J Neurosci
          <year>2013</year>
<volume>33</volume>
<issue>18</issue>
<fpage>7856</fpage>
<lpage>7869</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.3372-12.2013</pub-id>
<pub-id pub-id-type="pmid">23637177</pub-id>
</element-citation>
</ref>
<ref id="CR72">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stefansson</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Sigurdsson</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Steinthorsdottir</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Bjornsdottir</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sigmundsson</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ghosh</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Neuregulin 1 and susceptibility to schizophrenia</article-title>
<source/>Am J Hum Genet
          <year>2002</year>
<volume>71</volume>
<issue>4</issue>
<fpage>877</fpage>
<lpage>892</lpage>
<pub-id pub-id-type="doi">10.1086/342734</pub-id>
<pub-id pub-id-type="pmid">12145742</pub-id>
</element-citation>
</ref>
<ref id="CR73">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harrison</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Law</surname>
<given-names>AJ</given-names>
</name>
</person-group>
<article-title>Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology</article-title>
<source/>Biol Psychiatry
          <year>2006</year>
<volume>60</volume>
<issue>2</issue>
<fpage>132</fpage>
<lpage>140</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2005.11.002</pub-id>
<pub-id pub-id-type="pmid">16442083</pub-id>
</element-citation>
</ref>
<ref id="CR74">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Del Pino</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Garcia-Frigola</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Dehorter</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Brotons-Mas</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Alvarez-Salvado</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Martinez de Lagran</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Erbb4 deletion from fast-spiking interneurons causes schizophrenia-like phenotypes</article-title>
<source/>Neuron
          <year>2013</year>
<volume>79</volume>
<issue>6</issue>
<fpage>1152</fpage>
<lpage>1168</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2013.07.010</pub-id>
<pub-id pub-id-type="pmid">24050403</pub-id>
</element-citation>
</ref>
<ref id="CR75">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fazzari</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Paternain</surname>
<given-names>AV</given-names>
</name>
<name>
<surname>Valiente</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pla</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Lujan</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Lloyd</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Control of cortical GABA circuitry development by Nrg1 and ErbB4 signalling</article-title>
<source/>Nature
          <year>2010</year>
<volume>464</volume>
<issue>7293</issue>
<fpage>1376</fpage>
<lpage>1380</lpage>
<pub-id pub-id-type="doi">10.1038/nature08928</pub-id>
<pub-id pub-id-type="pmid">20393464</pub-id>
</element-citation>
</ref>
<ref id="CR76">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ting</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Tao</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Neuregulin 1 promotes excitatory synapse development and function in GABAergic interneurons</article-title>
<source/>J Neurosci
          <year>2011</year>
<volume>31</volume>
<issue>1</issue>
<fpage>15</fpage>
<lpage>25</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2538-10.2011</pub-id>
<pub-id pub-id-type="pmid">21209185</pub-id>
</element-citation>
</ref>
<ref id="CR77">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Munro</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Nash</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pigoni</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lichtenthaler</surname>
<given-names>SF</given-names>
</name>
<name>
<surname>Gunnersen</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>Functions of the Alzheimer's disease protease BACE1 at the synapse in the central nervous system</article-title>
<source/>J Mol Neurosci
          <year>2016</year>
<volume>60</volume>
<issue>3</issue>
<fpage>305</fpage>
<lpage>315</lpage>
<pub-id pub-id-type="doi">10.1007/s12031-016-0800-1</pub-id>
<pub-id pub-id-type="pmid">27456313</pub-id>
</element-citation>
</ref>
<ref id="CR78">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuhn</surname>
<given-names>PH</given-names>
</name>
<name>
<surname>Koroniak</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hogl</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Colombo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zeitschel</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Willem</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Secretome protein enrichment identifies physiological BACE1 protease substrates in neurons</article-title>
<source/>EMBO J
          <year>2012</year>
<volume>31</volume>
<issue>14</issue>
<fpage>3157</fpage>
<lpage>3168</lpage>
<pub-id pub-id-type="doi">10.1038/emboj.2012.173</pub-id>
<pub-id pub-id-type="pmid">22728825</pub-id>
</element-citation>
</ref>
<ref id="CR79">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pigoni</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wanngren</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kuhn</surname>
<given-names>PH</given-names>
</name>
<name>
<surname>Munro</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Gunnersen</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Takeshima</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Seizure protein 6 and its homolog seizure 6-like protein are physiological substrates of BACE1 in neurons</article-title>
<source/>Mol Neurodegener
          <year>2016</year>
<volume>11</volume>
<issue>1</issue>
<fpage>67</fpage>
<pub-id pub-id-type="doi">10.1186/s13024-016-0134-z</pub-id>
<pub-id pub-id-type="pmid">27716410</pub-id>
</element-citation>
</ref>
<ref id="CR80">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shimizu-Nishikawa</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kajiwara</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kimura</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Katsuki</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sugaya</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Cloning and expression of SEZ-6, a brain-specific and seizure-related cDNA</article-title>
<source/>Brain Res Mol Brain Res
          <year>1995</year>
<volume>28</volume>
<issue>2</issue>
<fpage>201</fpage>
<lpage>210</lpage>
<pub-id pub-id-type="doi">10.1016/0169-328X(94)00203-Q</pub-id>
<pub-id pub-id-type="pmid">7723619</pub-id>
</element-citation>
</ref>
<ref id="CR81">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gunnersen</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Fuller</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>De Silva</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Britto</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Hammond</surname>
<given-names>VE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Sez-6 proteins affect dendritic arborization patterns and excitability of cortical pyramidal neurons</article-title>
<source/>Neuron
          <year>2007</year>
<volume>56</volume>
<issue>4</issue>
<fpage>621</fpage>
<lpage>639</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2007.09.018</pub-id>
<pub-id pub-id-type="pmid">18031681</pub-id>
</element-citation>
</ref>
<ref id="CR82">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Quitsch</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Berhorster</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Liew</surname>
<given-names>CW</given-names>
</name>
<name>
<surname>Richter</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kreienkamp</surname>
<given-names>HJ</given-names>
</name>
</person-group>
<article-title>Postsynaptic shank antagonizes dendrite branching induced by the leucine-rich repeat protein Densin-180</article-title>
<source/>J Neurosci
          <year>2005</year>
<volume>25</volume>
<issue>2</issue>
<fpage>479</fpage>
<lpage>487</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2699-04.2005</pub-id>
<pub-id pub-id-type="pmid">15647492</pub-id>
</element-citation>
</ref>
<ref id="CR83">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Havik</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Rokke</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Dagyte</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Stavrum</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Bramham</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Steen</surname>
<given-names>VM</given-names>
</name>
</person-group>
<article-title>Synaptic activity-induced global gene expression patterns in the dentate gyrus of adult behaving rats: induction of immunity-linked genes</article-title>
<source/>Neuroscience
          <year>2007</year>
<volume>148</volume>
<issue>4</issue>
<fpage>925</fpage>
<lpage>936</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroscience.2007.07.024</pub-id>
<pub-id pub-id-type="pmid">17764852</pub-id>
</element-citation>
</ref>
<ref id="CR84">
<label>84.</label>
<mixed-citation publication-type="other">Miyazaki T, Hashimoto K, Uda A, Sakagami H, Nakamura Y, Saito SY, Takeshima H. Disturbance of cerebellar synaptic maturation in mutant mice lacking BSRPs, a novel brain-specific receptor-like protein family. FEBS Lett. 2006;580(17):4057–4064. doi:10.1016/j.febslet.2006.06.043.</mixed-citation>
</ref>
<ref id="CR85">
<label>85.</label>
<mixed-citation publication-type="other">Stutzer I, Selevsek N, Esterhazy D, Schmidt A, Aebersold R, &amp; Stoffel M. Systematic proteomic analysis identifies beta-site amyloid precursor protein cleaving enzyme 2 and 1 (BACE2 and BACE1) substrates in pancreatic beta-cells. J Biol Chem. 2013;288(15):10536–10547. doi:10.1074/jbc.M112.444703.</mixed-citation>
</ref>
<ref id="CR86">
<label>86.</label>
<mixed-citation publication-type="other">He W, Hu J, Xia Y, &amp; Yan R. Beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) regulates Notch signaling by controlling the cleavage of Jagged 1 (Jag1) and Jagged 2 (Jag2) proteins. J Biol Chem. 2014;289(30):20630–20637. doi:10.1074/jbc.M114.579862.</mixed-citation>
</ref>
<ref id="CR87">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>He</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Tsubota</surname>
<given-names>KE</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>BACE1 regulates hippocampal astrogenesis via the Jagged1-notch pathway</article-title>
<source/>Cell Rep
          <year>2013</year>
<volume>4</volume>
<issue>1</issue>
<fpage>40</fpage>
<lpage>49</lpage>
<pub-id pub-id-type="doi">10.1016/j.celrep.2013.06.005</pub-id>
<pub-id pub-id-type="pmid">23831026</pub-id>
</element-citation>
</ref>
<ref id="CR88">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gaiano</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Fishell</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>The role of notch in promoting glial and neural stem cell fates</article-title>
<source/>Annu Rev Neurosci
          <year>2002</year>
<volume>25</volume>
<fpage>471</fpage>
<lpage>490</lpage>
<pub-id pub-id-type="doi">10.1146/annurev.neuro.25.030702.130823</pub-id>
<pub-id pub-id-type="pmid">12052917</pub-id>
</element-citation>
</ref>
<ref id="CR89">
<label>89.</label>
<mixed-citation publication-type="other">Morrison SJ, Perez SE, Qiao Z, Verdi JM, Hicks C, Weinmaster G, &amp; Anderson DJ. Transient Notch activation initiates an irreversible switch from neurogenesis to gliogenesis by neural crest stem cells. Cell. 2000;101(5):499–510.</mixed-citation>
</ref>
<ref id="CR90">
<label>90.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilhelmsson</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Faiz</surname>
<given-names>M</given-names>
</name>
<name>
<surname>de Pablo</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Sjoqvist</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Andersson</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Widestrand</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Astrocytes negatively regulate neurogenesis through the Jagged1-mediated notch pathway</article-title>
<source/>Stem Cells
          <year>2012</year>
<volume>30</volume>
<issue>10</issue>
<fpage>2320</fpage>
<lpage>2329</lpage>
<pub-id pub-id-type="doi">10.1002/stem.1196</pub-id>
<pub-id pub-id-type="pmid">22887872</pub-id>
</element-citation>
</ref>
<ref id="CR91">
<label>91.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alberi</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Badie</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Smith-Hicks</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Activity-induced notch signaling in neurons requires arc/Arg3.1 and is essential for synaptic plasticity in hippocampal networks</article-title>
<source/>Neuron
          <year>2011</year>
<volume>69</volume>
<issue>3</issue>
<fpage>437</fpage>
<lpage>444</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2011.01.004</pub-id>
<pub-id pub-id-type="pmid">21315255</pub-id>
</element-citation>
</ref>
<ref id="CR92">
<label>92.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stump</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Durrer</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Lutolf</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Suter</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>Notch1 and its ligands Delta-like and jagged are expressed and active in distinct cell populations in the postnatal mouse brain</article-title>
<source/>Mech Dev
          <year>2002</year>
<volume>114</volume>
<issue>1–2</issue>
<fpage>153</fpage>
<lpage>159</lpage>
<pub-id pub-id-type="doi">10.1016/S0925-4773(02)00043-6</pub-id>
<pub-id pub-id-type="pmid">12175503</pub-id>
</element-citation>
</ref>
<ref id="CR93">
<label>93.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Presente</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Boyles</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Serway</surname>
<given-names>CN</given-names>
</name>
<name>
<surname>de Belle</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Andres</surname>
<given-names>AJ</given-names>
</name>
</person-group>
<article-title>Notch is required for long-term memory in drosophila</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2004</year>
<volume>101</volume>
<issue>6</issue>
<fpage>1764</fpage>
<lpage>1768</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0308259100</pub-id>
<pub-id pub-id-type="pmid">14752200</pub-id>
</element-citation>
</ref>
<ref id="CR94">
<label>94.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clarke</surname>
<given-names>LE</given-names>
</name>
<name>
<surname>Barres</surname>
<given-names>BA</given-names>
</name>
</person-group>
<article-title>Emerging roles of astrocytes in neural circuit development</article-title>
<source/>Nat Rev Neurosci
          <year>2013</year>
<volume>14</volume>
<issue>5</issue>
<fpage>311</fpage>
<lpage>321</lpage>
<pub-id pub-id-type="doi">10.1038/nrn3484</pub-id>
<pub-id pub-id-type="pmid">23595014</pub-id>
</element-citation>
</ref>
<ref id="CR95">
<label>95.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Araque</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Parpura</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Sanzgiri</surname>
<given-names>RP</given-names>
</name>
<name>
<surname>Haydon</surname>
<given-names>PG</given-names>
</name>
</person-group>
<article-title>Tripartite synapses: glia, the unacknowledged partner</article-title>
<source/>Trends Neurosci
          <year>1999</year>
<volume>22</volume>
<issue>5</issue>
<fpage>208</fpage>
<lpage>215</lpage>
<pub-id pub-id-type="doi">10.1016/S0166-2236(98)01349-6</pub-id>
<pub-id pub-id-type="pmid">10322493</pub-id>
</element-citation>
</ref>
<ref id="CR96">
<label>96.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bushong</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Martone</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>YZ</given-names>
</name>
<name>
<surname>Ellisman</surname>
<given-names>MH</given-names>
</name>
</person-group>
<article-title>Protoplasmic astrocytes in CA1 stratum radiatum occupy separate anatomical domains</article-title>
<source/>J Neurosci
          <year>2002</year>
<volume>22</volume>
<issue>1</issue>
<fpage>183</fpage>
<lpage>192</lpage>
<pub-id pub-id-type="pmid">11756501</pub-id>
</element-citation>
</ref>
<ref id="CR97">
<label>97.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Halassa</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Fellin</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Takano</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Haydon</surname>
<given-names>PG</given-names>
</name>
</person-group>
<article-title>Synaptic islands defined by the territory of a single astrocyte</article-title>
<source/>J Neurosci
          <year>2007</year>
<volume>27</volume>
<issue>24</issue>
<fpage>6473</fpage>
<lpage>6477</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.1419-07.2007</pub-id>
<pub-id pub-id-type="pmid">17567808</pub-id>
</element-citation>
</ref>
<ref id="CR98">
<label>98.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oberheim</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Takano</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>X</given-names>
</name>
<name>
<surname>He</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>F</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Uniquely hominid features of adult human astrocytes</article-title>
<source/>J Neurosci
          <year>2009</year>
<volume>29</volume>
<issue>10</issue>
<fpage>3276</fpage>
<lpage>3287</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.4707-08.2009</pub-id>
<pub-id pub-id-type="pmid">19279265</pub-id>
</element-citation>
</ref>
<ref id="CR99">
<label>99.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beattie</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Stellwagen</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Morishita</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Bresnahan</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Ha</surname>
<given-names>BK</given-names>
</name>
<name>
<surname>Von Zastrow</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Control of synaptic strength by glial TNFalpha</article-title>
<source/>Science
          <year>2002</year>
<volume>295</volume>
<issue>5563</issue>
<fpage>2282</fpage>
<lpage>2285</lpage>
<pub-id pub-id-type="doi">10.1126/science.1067859</pub-id>
<pub-id pub-id-type="pmid">11910117</pub-id>
</element-citation>
</ref>
<ref id="CR100">
<label>100.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benilova</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Gallardo</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ungureanu</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Castillo Cano</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Snellinx</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ramakers</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The Alzheimer disease protective mutation A2T modulates kinetic and thermodynamic properties of amyloid-beta (Abeta) aggregation</article-title>
<source/>J Biol Chem
          <year>2014</year>
<volume>289</volume>
<issue>45</issue>
<fpage>30977</fpage>
<lpage>30989</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M114.599027</pub-id>
<pub-id pub-id-type="pmid">25253695</pub-id>
</element-citation>
</ref>
<ref id="CR101">
<label>101.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jonsson</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Atwal</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Steinberg</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Snaedal</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jonsson</surname>
<given-names>PV</given-names>
</name>
<name>
<surname>Bjornsson</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A mutation in APP protects against Alzheimer's disease and age-related cognitive decline</article-title>
<source/>Nature
          <year>2012</year>
<volume>488</volume>
<issue>7409</issue>
<fpage>96</fpage>
<lpage>99</lpage>
<pub-id pub-id-type="doi">10.1038/nature11283</pub-id>
<pub-id pub-id-type="pmid">22801501</pub-id>
</element-citation>
</ref>
<ref id="CR102">
<label>102.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maloney</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Bainbridge</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Gustafson</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kyauk</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Steiner</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Molecular mechanisms of Alzheimer disease protection by the A673T allele of amyloid precursor protein</article-title>
<source/>J Biol Chem
          <year>2014</year>
<volume>289</volume>
<issue>45</issue>
<fpage>30990</fpage>
<lpage>31000</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M114.589069</pub-id>
<pub-id pub-id-type="pmid">25253696</pub-id>
</element-citation>
</ref>
<ref id="CR103">
<label>103.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kennedy</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Stamford</surname>
<given-names>AW</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Cox</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Cumming</surname>
<given-names>JN</given-names>
</name>
<name>
<surname>Dockendorf</surname>
<given-names>MF</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The BACE1 inhibitor verubecestat (MK-8931) reduces CNS beta-amyloid in animal models and in Alzheimer's disease patients</article-title>
<source/>Sci Transl Med
          <year>2016</year>
<volume>8</volume>
<issue>363</issue>
<fpage>363ra150</fpage>
<pub-id pub-id-type="doi">10.1126/scitranslmed.aad9704</pub-id>
<pub-id pub-id-type="pmid">27807285</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>